CAS NO: | 609799-22-6 |
生物活性 | Tasimelteon (BMS-214778) is an orally active and selectivedualmelatonin receptor agonist(DMRA). Tasimelteon has 2.1-4.4 times greater affinity for theMT2receptor than for theMT1receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24)[1][2]. | ||||||||||||||||
体外研究 (In Vitro) | Tasimelteon (BMS-214778) has 2.1-4.4 times greater affinity for the MT2 receptor believed to mediate circadian rhythm phase-shifting (Ki=0.0692 nM and Ki=0.17 nM in NIH-3T3 and CHO-K1 cells, respectively), than for the MT1 receptor (Ki=0.304 nM and Ki=0.35 nM, respectively). Tasimelteon has no appreciable affinity for more than 160 other pharmacologically relevant receptors and several enzymes[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 245.32 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C15H19NO2 | ||||||||||||||||
CAS 号 | 609799-22-6 | ||||||||||||||||
中文名称 | 他司美琼 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 33 mg/mL(134.52 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |